A new £6.8 million National Centre for Hyperpolarised MRI based across the Universities of Leeds and York will aim to transform diagnosis and treatment of patients suffering from cancer, heart disease and musculoskeletal diseases. The funding from the Medical Research Council is part of a package worth more than £230 million for universities across Britain announced by Chancellor of the Exchequer George Osborne in 2014. The aim of the centre is the clinical translation of a hyperpolarised MRI method known as Signal Amplification by Reversible Exchange, or SABRE, which has been developed by scientists at the University of York. In Leeds, the centre will be located within Leeds Teaching Hospitals NHS Trust in order to facilitate clinical studies. It will include a new 3T clinical MRI scanner with multinuclear capability, patient facilities, pharmacological laboratories and other designated space. There are plans to expand to integrated PET studies in the future.

We are currently recruiting researchers and technologists with experience in molecular MRI, in support of this facility. The University Academic Fellowship scheme offers additional opportunities for researchers with an interest in biomedical imaging.

The development of the SABRE technique in York is being driven forward at a £7m purpose-built research facility that opened last year. The Centre for Hyperpolarisation in Magnetic Resonance (CHyM) houses over 30 research scientists and combines the world-class expertise of research scientists from the University of York’s departments of Chemistry, Psychology and Biology, as well as the Hull York Medical School. The SABRE project has already gained over £12m investment from the Welcome Trust, Bruker Biospin and the Engineering and Physical Sciences Research Council (EPSRC.